Hemorrhoids Treatment Market Overview
The Hemorrhoids Treatment Market is experiencing steady growth as awareness of gastrointestinal health increases, the global population ages, and patients gain access to a broader range of pharmaceutical and procedural treatment options. Demand is being supported by changing lifestyles, dietary habits, increasing healthcare expenditure, and growing preference for effective and minimally invasive approaches to hemorrhoid management.
As per MRFR analysis, the global Hemorrhoids Treatment Market was valued at USD 1,441.59 Million in 2024. The market is projected to grow from USD 1,556.57 Million in 2025 to USD 2,994.6 Million by 2035, registering a compound annual growth rate (CAGR) of 6.83% during the forecast period 2025–2035.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
Sample Report: Request Free Sample
Key market players driving innovation and competitiveness in the Hemorrhoids Treatment Market include:
Johnson & Johnson (US)
Bayer AG (DE)
Medtronic (US)
Stryker Corporation (US)
Boston Scientific (US)
Hollister Incorporated (US)
Coloplast A/S (DK)
Smith & Nephew (GB)
3M Company (US)
The market is being supported by increasing awareness of available hemorrhoid treatment options and growing patient preference for convenient, effective, and less invasive therapies. Topical treatments remain widely used because of their accessibility and ease of administration, while minimally invasive procedures are gaining attention because they can offer shorter recovery times and reduced discomfort compared with conventional surgical approaches.
The aging population is another important market driver. Older adults can be more susceptible to hemorrhoidal conditions, increasing the need for treatment options across pharmaceutical, outpatient, and surgical settings. At the same time, improvements in healthcare infrastructure and access to specialist care are helping patients seek treatment earlier and supporting adoption of advanced management approaches.
Purchase the Complete Report for Strategic Insights and Market Forecasts:
Purchase Full Report: Buy the Complete Report
The Hemorrhoids Treatment Market is segmented by severity level, treatment type, distribution channel, and patient demographics. By severity level, the market includes Mild, Moderate, and Severe cases. By treatment type, it covers Topical Treatments, Oral Medications, Minimally Invasive Procedures, and Surgical Procedures. Distribution channels include Pharmacies, Online Retail, Hospitals, and Clinics, while patient demographics include Adults, Elderly, Pregnant Women, and Children.
Topical Treatments represent a major segment of the market because of their convenience, availability, and suitability for managing many mild to moderate symptoms. Minimally invasive procedures are also gaining momentum, with approaches such as rubber band ligation, sclerotherapy, and infrared coagulation offering alternatives to more extensive surgical interventions.
Pharmacies remain an important distribution channel because they provide convenient access to commonly used hemorrhoid treatments and professional guidance. Online retail is emerging as a rapidly expanding channel as consumers increasingly value convenience, privacy, and home delivery for healthcare products. Hospitals and clinics remain essential for specialist evaluation and procedural treatment, particularly for severe or persistent cases.
North America held the largest regional share in 2024, supported by advanced healthcare systems, high awareness of treatment options, strong healthcare spending, and adoption of minimally invasive procedures. Europe also represents a significant market, while Asia-Pacific is expected to provide attractive growth opportunities due to its large patient population, improving healthcare infrastructure, rising healthcare expenditure, and increasing awareness of available treatment options.
Recent Developments:
1. Minimally invasive hemorrhoid procedures are gaining adoption as patients and healthcare providers increasingly seek treatments associated with lower discomfort and shorter recovery periods.
2. Pharmaceutical companies are continuing to develop topical formulations, oral therapies, and over-the-counter products aimed at improving symptom management and treatment convenience.
3. Online retail channels are expanding the availability of hemorrhoid treatment products and providing consumers with greater privacy and convenience.
4. Healthcare providers are increasing awareness and education around gastrointestinal health, encouraging earlier evaluation and treatment of persistent symptoms.
5. Medical device companies are advancing technologies for minimally invasive and surgical hemorrhoid procedures to improve treatment precision and patient outcomes.
Browse In-depth Market Research Report (Pages, Charts, Tables, Figures):
Hemorrhoids Treatment Market Report
Reasons to Buy the Report:
1. Provides comprehensive insights into the Hemorrhoids Treatment Market, including market dynamics, trends, opportunities, and growth drivers.
2. Offers market size and forecast analysis from 2025 to 2035, including the projected 6.83% CAGR.
3. Includes detailed segmentation analysis by severity level, treatment type, distribution channel, and patient demographics.
4. Provides competitive intelligence on leading pharmaceutical and medical device companies operating in the market.
5. Supports strategic planning and investment decisions through market forecasts, treatment trends, regional analysis, and competitive developments.
Future Outlook:
The future of the Hemorrhoids Treatment Market is expected to remain positive as healthcare awareness increases and treatment options continue to evolve. Opportunities are expected across topical therapies, oral medications, minimally invasive procedures, advanced surgical technologies, and digital healthcare services. The expansion of online retail and telehealth-supported consultations may also improve access to treatment and follow-up care.
By 2035, the market is projected to reach USD 2,994.6 Million. Continued innovation in minimally invasive procedures, growing demand for convenient treatment options, increasing healthcare expenditure, and demographic changes are expected to support sustained market development.
➤➤Explore MRFR’s Related Ongoing Coverage In Healthcare Domain:
1. Gastrointestinal Therapeutics Market
2. Gastrointestinal Drugs Market
6. Inflammatory Bowel Disease Treatment Market
7. Irritable Bowel Syndrome Treatment Market
8. Constipation Treatment Market
10. Gastroesophageal Reflux Disease Market
11. Proton Pump Inhibitors Market
